Angela King, PhD, is a regulatory leader with over 15 years’ experience guiding regulatory strategy and delivery across multi country clinical trials in the EU and globally. She specialises in EU CTR execution, informed consent governance, and end to end clinical trial submission lifecycle management.
Angela is known for driving lean process optimisation and supporting the adoption of eConsent across global programs. She is widely recognised for her ability to translate complex regulatory guidance into practical, site ready processes that improve operational clarity and compliance.
An active ACRO member, Angela contributed to the Decentralized Trials Working Party, bringing a pragmatic and operationally grounded perspective to DCT adoption, risk mitigation, and regulatory expectations.
As a subject matter expert in serious breach assessment and global reporting requirements, Angela is valued for her clear, collaborative leadership and her focus on producing audit ready, implementable regulatory practices. She brings an operations focused lens to implementing ICH GCP E6(R3) in real world site environments—bridging policy, oversight, and frontline execution.
